Publications by authors named "Z Beretzky"

Background: Several different coronavirus disease (COVID-19) vaccines were authorized and distributed all over the world, including Hungary, but vaccination rates and acceptance of the different vaccines varied through 2021 and subsequent years. In Hungary Western vaccines and the Chinese and Russian vaccines were available in early 2021. Understanding preference and willingness to pay (WTP) for the COVID-19 vaccine could provide information for policy decision making to control the COVID-19 pandemic.

View Article and Find Full Text PDF

Background: Budget constraints in health-care systems have led to the popularity of Cost Effectiveness Thresholds (CET) to achieve efficient allocation of resources. The capability approach has been hailed for its potentially richer evaluative capabilities compared to the QALY in terms of thresholds. Extensive research, however, is still limited.

View Article and Find Full Text PDF

Background: Cost-of-illness studies are widely used for healthcare decision-making in chronic conditions. Our aim was to assess the cost-of-illness of adult atopic dermatitis (AD) from the societal perspective in Hungary.

Methods: We conducted a multicentre, cross-sectional questionnaire survey between February 2018 and January 2021.

View Article and Find Full Text PDF

Introduction: Population norms are available for several generic health-related quality of life questionnaires, but rarely for disease- or specialty-specific questionnaires. The aim of our study was to calculate population norms for the Dermatology Life Quality Index (DLQI) score..

View Article and Find Full Text PDF

Background: Atopic dermatitis (AD) is a common chronic inflammatory skin disorder affecting up to 10% of adults. The EQ-5D is the most commonly used generic preference-accompanied measure to generate quality-adjusted life years (QALYs) for economic evaluations.

Objectives: We aimed to compare psychometric properties of the three-level and five-level EQ-5D (EQ-5D-3L and EQ-5D-5L) in adult patients with AD.

View Article and Find Full Text PDF